Stock Earnings

Question 1

What are Cullinan Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Cullinan Therapeutics Inc has a total asset of $621, Net loss of $-167

Question 2

What are the key financial ratios for CGEM?

Accepted Answer

Cullinan Therapeutics Inc's Current ratio is 20.03, has a Net margin is 0, sales per share of $0.

Question 3

How is Cullinan Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Cullinan Therapeutics Inc data is not available.

Question 4

Is Cullinan Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Cullinan Therapeutics Inc has a net loss of $-167

Question 5

Does Cullinan Therapeutics Inc have any liabilities?

Accepted Answer

yes, Cullinan Therapeutics Inc has liability of 31

Question 6

How many outstanding shares for Cullinan Therapeutics Inc?

Accepted Answer

Cullinan Therapeutics Inc has a total outstanding shares of 58.51

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	18	0
Revenue Growth (YoY)	--	--	--	-100%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	56	54	42	38	29	17
Research & Development	184	142	148	91	57	43
Operating Expenses	241	196	190	130	86	60
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-216	-167	-169	151	-67	-59
Income Tax Expense	--	0	-14	42	--	--
Net Income	-216	-167	-153	111	-65	-51
Net Income Growth	51%	9%	-238%	-271%	27%	155%
Shares Outstanding (Diluted)	59.07	53.77	41.55	46.64	43.08	41.4
Shares Change (YoY)	1%	28.99%	-11%	8%	4%	0%
EPS (Diluted)	-3.68	-3.11	-3.68	2.38	-1.52	-1.25
EPS Growth	50%	-16%	-254.99%	-257%	22%	150%
Free Cash Flow	-174	-145	-134	-127	-43	-29
Free Cash Flow Per Share	-2.94	-2.69	-3.22	-2.72	-0.99	-0.7
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-372.22%	0%
Profit Margin	0%	0%	0%	0%	-361.11%	0%
Free Cash Flow Margin	0%	0%	0%	0%	-238.88%	0%
EBITDA	-241	-196	-190	-130	-67	-60
EBITDA Margin	0%	0%	0%	0%	-372.22%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-241	-196	-190	-130	-67	-60
EBIT Margin	0%	0%	0%	0%	-372.22%	0%
Effective Tax Rate	--	0%	8.28%	27.81%	--	--

Cullinan Therapeutics Inc (CGEM) Price